United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 1997_register executive 2010-09-24 article Rules and Regulations D09002ee1be022ca1 D09002ee1be022d25 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States Food and Drug Administration originator org United States Government Agency or Subagency The Food and Drug Administration (FDA) is consolidating a list of drugs, previously determined by rulemaking to be new drugs, into one section. This document also removes the sections now providing for these drugs, except for certain information in the regulations that FDA considers to be necessary. This action, which will make the regulations more concise and efficient, is being taken in response to the President's regulatory reinvention initiative (REGO). 62 FR 12083 https://www.govinfo.gov/app/details/FR-1997-03-14/97-6411 97-6411 fr14mr97-5 RIN 0910-AA53 4160-01-F Docket No. 96N-0183 https://www.govinfo.gov/app/details/FR-1997-03-14/97-6411 https://www.govinfo.gov/content/pkg/FR-1997-03-14/html/97-6411.htm https://www.govinfo.gov/content/pkg/FR-1997-03-14/pdf/97-6411.pdf 3 p. 12083 12085 62 FR 12083 Title 21 Part 200 21 CFR Part 200 Title 21 Part 250 21 CFR Part 250 Title 21 Part 310 21 CFR Part 310 RIN 0910-AA53 Consolidation of Drug Regulations; Federal Register Vol. 62, Issue RULE 97-6411 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Docket No. 96N-0183 4160-01-F 97-6411 Final rule.

The Food and Drug Administration (FDA) is consolidating a list of drugs, previously determined by rulemaking to be new drugs, into one section. This document also removes the sections now providing for these drugs, except for certain information in the regulations that FDA considers to be necessary. This action, which will make the regulations more concise and efficient, is being taken in response to the President's regulatory reinvention initiative (REGO).

April 14, 1997. Mary E. Catchings, Food and Drug Administration, Center for Drug Evaluation and Research (HFD-7), 7500 Standish Pl., Rockville, MD 20855, 301-594-2041. Vol. 62, no. 50 Office of the Federal Register, National Archives and Records Administration 1997-03-14 continuing daily deposited born digital 472 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-1997-03-14 P0b002ee180a3db95 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr14mr97 https://www.govinfo.gov/app/details/FR-1997-03-14 https://www.govinfo.gov/content/pkg/FR-1997-03-14/pdf/FR-1997-03-14.pdf fdlp 12067 12529 DGPO 2010-09-24 2023-05-06 FR-1997-03-14 machine generated eng FR FR-1997-03-14 62 50